Prescription Medicines Division Strategy Board

The Prescription Medicines Division Strategy Board comprises fourteen representatives elected by the members of IPHA’s Prescription Medicines Division for a three year period. The Strategy Board defines the strategy and policy for the Division. Membership of the Strategy Board is open to every member company. The Strategy Board comprises:

• Gerald Farrell, Eli Lilly & Company (Ireland) Ltd (Chairman)
• Francis Lynch, A Menarini Pharmaceuticals Ireland Ltd
• John McLaughlin, sanofi-aventis Ireland Ltd.
• Gerry Burke, AstraZeneca Pharmaceuticals (Ireland) Ltd
• Mark Rodgers, Roche Products Ireland Ltd
• Loretto Callaghan, Novartis Ireland Ltd
• Neil Boyle, Merck Sharp & Dohme Ireland (Human Health) Ltd
• Geraldine Murphy, Leo Pharma
• David Gallagher, Pfizer Healthcare Ireland 
• Craig Skelton, Abbott Laboratories (Ireland) Ltd  
• Leisha Daly, Janssen-Cilag Ltd
• Colette Langan, Bristol-Myers Squibb Pharmaceuticals
• Sally Storey, GlaxoSmithKline
• Michael Byrne, Amgen Ireland Limited